<DOC>
	<DOC>NCT00192595</DOC>
	<brief_summary>The purpose of the study is to compare the effectiveness of 3 different treatment regimens in reducing or clearing the Hepatitis B Virus in patients infected with HIV and Hepatitis B (co-infection)</brief_summary>
	<brief_title>Tenofovir in HIV/HBV Coinfection</brief_title>
	<detailed_description>A randomised multi-centre trial of tenofovir vs lamivudine vs tenofovir/lamivudine in antiretroviral naïve subjects with HIV/HBV co-infection over 48 weeks (Clinical Trial A). Plus, a 12 week viral kinetic sub-study comparing a sub-group of the patients on Clinical Trial A with a group of therapy naïve HBV mono-infected subjects (Substudy A1)</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Written informed consent Documented HIV infection (positive serology for HIV1 and detectable HIV1 RNA) Age 18 70 years HBV DNA &gt; 105 copies/ml HBsAg positive &gt;6 months or HBsAg positive and anti HB core IgM negative Creatinine &lt;= 2.0mg/dl (&lt;= 0.2 mmol/L) Platelet count &gt;= 50,000/mm HIV1 antiretroviral therapy naïve No prior exposure to antiHBV agents (LAM, adefovir, TDF) although prior IFN treatment allowed HCVRNA positive or AntiHAV IgM positive Acute hepatitis (serum ALT &gt; 1000 U/L) Active opportunistic infection Other causes of chronic liver disease identified (autoimmune hepatitis, hemochromatosis, Wilsons disease, alfa1antitrypsin deficiency) Concurrent malignancy requiring cytotoxic chemotherapy Decompensated or Child's C cirrhosis Alfafetoprotein (AFP) &gt; 3X ULN (unless negative CT scan or MRI within 3 months of entry date) Pregnancy or lactation Any other condition which in the opinion of the investigator might interfere with compliance or outcome of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>HIV</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>